:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Lenguaje:
Publicado:	Zenodo 2025
Acceso en línea:	https://doi.org/10.5281/zenodo.14641826
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

SLX1B is active during transformation and controls relapse and resistance in human cancer.
por: Mamoor, Shahan
Publicado: (2025)

Adirf activation in chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Ribosomal activation in TNBC resistance in vitro.
por: Mamoor, Shahan
Publicado: (2025)

PAXX is activated in aging blood cells.
por: Mamoor, Shahan
Publicado: (2025)

Chemokine activation during cellular senescence.
por: Mamoor, Shahan
Publicado: (2024)

Importin 8 is activated in childhood brain cancer.
por: Mamoor, Shahan
Publicado: (2025)

Leukotriene activation in the blood of humans with high CRP.
por: Mamoor, Shahan
Publicado: (2025)

Alox5 activation in the blood of humans with high CRP.
por: Mamoor, Shahan
Publicado: (2025)

Gasdermin activation during lineage specification in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

TSC22D4 gene activation in Crohn's Disease.
por: Mamoor, Shahan
Publicado: (2025)

NLRP11 detects activation of CIDE cell death effectors.
por: Mamoor, Shahan
Publicado: (2025)

Arid5b is activated early in human embryonic development.
por: Mamoor, Shahan
Publicado: (2026)

Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)

Ep300 activation defines a common epigenetic route in chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: CAPN15.
por: Mamoor, Shahan
Publicado: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
por: Mamoor, Shahan
Publicado: (2026)

Fam234b is selectively activated during the first cell division of the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
por: Mamoor, Shahan
Publicado: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
por: Mamoor, Shahan
Publicado: (2025)

Kinase targeting in Luminal B breast cancer: DTYMK.
por: Mamoor, Shahan
Publicado: (2025)

Kinase targeting in Luminal B breast cancer: CDK5.
por: Mamoor, Shahan
Publicado: (2025)

Deletion of repeat B and C of Xist results in induction of SATB1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting for treatment of metastasis to the skeletal system: ABHD17B.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: BCL11B.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PPP1R12B.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
por: Mamoor, Shahan
Publicado: (2026)

NLRP7 engagement in transformation and etiology of chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
por: Mamoor, Shahan
Publicado: (2025)

Telomerase control of Xist through Trf2.
por: Mamoor, Shahan
Publicado: (2025)